The Canton of Zurich has commissioned the Hirslanden Group to provide and operate a Covid 19 vaccination centre for the population of the city of Zurich and the Dietikon district.

It is one of several cantonal vaccination centres in which the general population in the canton of Zurich is to be vaccinated in the period from April to August 2021. The award was preceded by a public tender for the contract.

The vaccination centre is being built in the Messe Zürich congress centre (halls 1 and 2) in an ideally accessible location. It will be ready by the end of February and with its 30 vaccination routes, will have a capacity of up to 4.000 vaccinations per day.

Zurich is the fourth canton to entrust Hirslanden with the provision of a Covid-19 vaccination centre. Hirslanden already operates centres in the cantons of Geneva, Thurgau and Zug (here in cooperation with the Cantonal Hospital Zug). 

About Hirslanden

The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 4 outpatient surgical units, 17 radiology institutes and 5 radiotherapy institutes. Together with public and private cooperation partners, Hirslanden focuses on the continuum of care and the promoting of high-quality, responsible, personalised and efficiently integrated healthcare. The Group has 2 506 affiliated doctors and 10 417 employees, 498 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2019/20 financial year, the Group generated turnover of CHF 1’804 million. As at 31.3.2020, the Group had treated 107’491 patients, amounting to a total of 471’717 inpatient days. In insurance terms, the patient mix consists of 49.2% basic, 29.3% semi-private, and 21.5% private insured patients.

Hirslanden is synonymous with first-class medical care provided by highly qualified medical specialists with many years of experience. As a system provider, the Group stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.

More information

Head Newsroom & Media Relations
Dr. Claude Kaufmann
Hirslanden AG
Corporate Office
Boulevard Lilienthal 2
CH-8152 Glattpark